ISRCTN89902973
Completed
未知
A one-year, prospective, observational, cohort, single centre study on the incidence, intensity, duration and identity of bacteraemia in patients undergoing transurethral resection of the prostate (TURP), extracorporeal shockwave lithotripsy (ESWL) and urinary catheter change
eeds Teaching Hospitals NHS Trust (UK)0 sites750 target enrollmentDecember 8, 2009
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- eeds Teaching Hospitals NHS Trust (UK)
- Enrollment
- 750
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Adults (18 years onwards)
- •2\. Both male and female (male only for the transurethral resection of the prostate \[TURP] cohort)
- •3\. Patient undergoing TURP, extracorporeal shock\-wave lithotripsy and urinary catheter change at the Leeds Teaching Hospital NHS Trust
Exclusion Criteria
- •1\. Age less than 18 years
- •2\. Not competent to consent for enrolment in the study
- •3\. Signs and symptoms of ongoing infection (of any source) at presentation to the hospital
- •4\. Use of systemic antibiotics within the 2 weeks of presentation to the hospital
- •5\. Recent (within 2 weeks) instrumentation of the urological tract (not including urethral or suprapubic catheterisation)
- •6\. Patient with poor veins, leading to difficult venous cannulation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A longitudinal prospective, observational, cohort study in lactating mothers and their newborns to further unravel the complexity of human milkNL-OMON53220utricia Research120
Completed
Not Applicable
This study is to survey on venous thromboembolism risk in cancer patients (lung or colorectal) who were about to start a new chemotherapy regimen.Health Condition 1: null- Colorectal or Lung (SCLC or NSCLC) cancerHealth Condition 2: C349- Malignant neoplasm of unspecifiedpart of bronchus or lungCTRI/2013/02/003380Sanofi Synthelabo India Ltd4,300
Active, not recruiting
Not Applicable
A prospective, non-randomized, mono-center, cohort study to evaluate the effects of 0.5mg intraocular Ranibizumab (Lucentis) injections on retinal function in patients with diabetic macular edema (DME) during twelve months - Ranibizumab short- and long-term effects on retinal function in wAMDRetinal function in patients with wet age-related macular degenerationMedDRA version: 14.0Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 10015919 - Eye disordersEUCTR2011-002202-70-DEniversitätsklinikum Schleswig-Holstein (UK-SH)
Active, not recruiting
Phase 1
A prospective, non-randomized, mono-center, cohort study to evaluate the short- and long-term effects of 0.5mg intraocular Ranibizumab (Lucentis) injections on retinal function in patients with wet age-related macular degeneration during twelve month - Ranibizumab short- and long-term effects on retinal function in wAMDRetinal function in patients with wet age-related macular degenerationMedDRA version: 12.1Level: LLTClassification code 10067791Term: Wet macular degenerationEUCTR2010-021777-37-DEniversitätsklinikum Schleswig-Holstein (UK-SH)20
Active, not recruiting
Not Applicable
The impact of rotavirus vaccine introduction in SAsevere gastroenteritisInfection - Other infectious diseasesACTRN12611000559910Children, Youth and Women's health Service200